Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 324
Gene Symbol: APC
APC
0.110 Biomarker disease HPO
Entrez Id: 5371
Gene Symbol: PML
PML
0.010 AlteredExpression disease BEFREE Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients. 18689862 2009
Entrez Id: 2065
Gene Symbol: ERBB3
ERBB3
0.010 Biomarker disease BEFREE HER3 overexpression was predominantly cytoplasmic; the rate of overexpression/amplification of HER3 in membrane and cytoplasm was 16% [ampullary cancer (AMP) (1/13; 8%), gallbladder cancer (GBC) (1/10; 10%), intra-hepatic cholangiocarcinoma (ICC) (6/26; 23%), extra-hepatic cholangiocarcinoma (ECC) (3/18; 17%)] and 24% [AMP (1/13; 8%), GBC (1/10; 10%), ICC (10/26; 38%), ECC (4/18; 22%)], respectively. 30335866 2018
Entrez Id: 1045
Gene Symbol: CDX2
CDX2
0.010 GeneticVariation disease BEFREE Additionally, we compared the expression rates of CK7, CK20, MUC1, MUC2, MUC5AC, MUC6, S100P, and CDX2 between the 2 main histologic subtypes of ampullary adenocarcinoma (NCC2019-0138).The patients who underwent PD for ampullary cancer were divided into 2 groups: very early recurrence and others. 31689805 2019
Entrez Id: 3845
Gene Symbol: KRAS
KRAS
0.020 GeneticVariation disease BEFREE Although the results showed overlapping of genomic alterations between the two subtypes, trends including more frequent KRAS alterations in pancreatobiliary-type ampullary carcinoma (61 vs 29%) and more frequent mutations in APC in intestinal-type ampullary carcinoma (43 vs 17%) were observed. 25975284 2015
Entrez Id: 324
Gene Symbol: APC
APC
0.110 GeneticVariation disease BEFREE Although the results showed overlapping of genomic alterations between the two subtypes, trends including more frequent KRAS alterations in pancreatobiliary-type ampullary carcinoma (61 vs 29%) and more frequent mutations in APC in intestinal-type ampullary carcinoma (43 vs 17%) were observed. 25975284 2015
Entrez Id: 57534
Gene Symbol: MIB1
MIB1
0.010 Biomarker disease BEFREE Both MIB-1 index and DNA ploidy provide important prognostic value and potentially complement the conventional prognostic factors in resectable ampulla of Vater carcinoma. 10203085 1999
Entrez Id: 4288
Gene Symbol: MKI67
MKI67
0.010 Biomarker disease BEFREE Both MIB-1 index and DNA ploidy provide important prognostic value and potentially complement the conventional prognostic factors in resectable ampulla of Vater carcinoma. 10203085 1999
Entrez Id: 675
Gene Symbol: BRCA2
BRCA2
0.020 GeneticVariation disease BEFREE During our study, a patient with an ampulla of Vater carcinoma was incidentally found to carry the BRCA2 c.156_157insAlu mutation, so we decided to test a consecutive series of additional 15 ampullary carcinomas for BRCA1/BRCA2 mutations using a combination of direct founder mutation testing and full gene analysis with next generation sequencing. 27532258 2016
Entrez Id: 29126
Gene Symbol: CD274
CD274
0.020 AlteredExpression disease BEFREE Eligible patients were aged 20-79 years, had biliary tract adenocarcinoma (intrahepatic bile duct cancer, extrahepatic bile duct cancer, gallbladder cancer, or ampullary cancer), Eastern Cooperative Oncology Group performance status 0 or 1, adequate hepatic, renal, and haematological function, and tumour tissue samples for PD-L1 expression analysis. 31109808 2019
Entrez Id: 836
Gene Symbol: CASP3
CASP3
0.010 Biomarker disease BEFREE Expression and prognostic significance of livin, caspase-3, and ki-67 in the progression of human ampullary carcinoma. 23343959 2013
Entrez Id: 4292
Gene Symbol: MLH1
MLH1
0.010 Biomarker disease BEFREE Four of 49 ACs (8.2%) were TMB-high/MSI-high and showed loss of MLH1 and PMS2. 31256008 2019
Entrez Id: 1999
Gene Symbol: ELF3
ELF3
0.030 Biomarker disease BEFREE Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma. 26806338 2016
Entrez Id: 3146
Gene Symbol: HMGB1
HMGB1
0.010 Biomarker disease BEFREE However, the prognostic value of HMGB1 in ampullary cancer has not been studied. 31399104 2019
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.020 AlteredExpression disease BEFREE However, there has been no study of p53 expression in extrahepatic bile duct/ampullary carcinoma. 7520348 1994
Entrez Id: 7157
Gene Symbol: TP53
TP53
0.020 GeneticVariation disease BEFREE KRAS and TP53 mutations are negative predictors of survival in AVCs, regardless of histotype. 27611608 2018
Entrez Id: 840
Gene Symbol: CASP7
CASP7
0.010 Biomarker disease BEFREE Livin is a new member of the inhibitor of apoptosis proteins family of proteins that interacts with downstream caspases, such as caspase-3, caspase-7, and caspase-9, however, its role in human ampullary carcinoma has not been clearly defined. 23343959 2013
Entrez Id: 842
Gene Symbol: CASP9
CASP9
0.010 Biomarker disease BEFREE Livin is a new member of the inhibitor of apoptosis proteins family of proteins that interacts with downstream caspases, such as caspase-3, caspase-7, and caspase-9, however, its role in human ampullary carcinoma has not been clearly defined. 23343959 2013
Entrez Id: 6696
Gene Symbol: SPP1
SPP1
0.010 AlteredExpression disease BEFREE Mean preoperative serum osteopontin levels as measured by competitive ELISA were 906 +/- 268 ng/ml in patients with ampullary cancer, 867 +/- 160 ng/ml in patients with an ampullary adenoma, 327.1 +/- 195.6 ng/ml in patients with nonmalignant periampullary diseases and 204 +/- 65 ng/ml in age-matched healthy controls (p < 0.001). 15136764 2004
Entrez Id: 5290
Gene Symbol: PIK3CA
PIK3CA
0.020 Biomarker disease BEFREE Moreover, we evaluated mutations in 16 key components of rat sarcoma (RAS), phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K), protein 53 (P53), transforming growth factor beta (TGF-β), and wingless/integrated (WNT) pathways, recently associated to AVC by whole-exome sequencing. 27611608 2018
Entrez Id: 5291
Gene Symbol: PIK3CB
PIK3CB
0.020 Biomarker disease BEFREE Moreover, we evaluated mutations in 16 key components of rat sarcoma (RAS), phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K), protein 53 (P53), transforming growth factor beta (TGF-β), and wingless/integrated (WNT) pathways, recently associated to AVC by whole-exome sequencing. 27611608 2018
Entrez Id: 5294
Gene Symbol: PIK3CG
PIK3CG
0.020 Biomarker disease BEFREE Moreover, we evaluated mutations in 16 key components of rat sarcoma (RAS), phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K), protein 53 (P53), transforming growth factor beta (TGF-β), and wingless/integrated (WNT) pathways, recently associated to AVC by whole-exome sequencing. 27611608 2018
Entrez Id: 5293
Gene Symbol: PIK3CD
PIK3CD
0.020 Biomarker disease BEFREE Moreover, we evaluated mutations in 16 key components of rat sarcoma (RAS), phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K), protein 53 (P53), transforming growth factor beta (TGF-β), and wingless/integrated (WNT) pathways, recently associated to AVC by whole-exome sequencing. 27611608 2018
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.010 Biomarker disease BEFREE Mutational analysis of the EGFR pathway genes may provide important insights into personalized treatment for patients with ampullary carcinoma. 24186143 2014
Entrez Id: 4594
Gene Symbol: MMUT
MMUT
0.010 GeneticVariation disease BEFREE Mutations of the human MUT S homologue 6 gene in ampullary carcinoma and gastric cancer. 9808525 1998